Cargando…

The Efficacy and Medium to Long-Term Follow-Up of Transcatheter Retrograde Closure of Perimembranous Ventricular Septal Defects via the Femoral Artery With Amplatzer Duct Occluder II in Children

Objective: The aim of this study was to assess the efficacy and safety of transcatheter retrograde closure of perimembranous ventricular septal defect (pmVSD) via the femoral artery with an Amplatzer Duct Occluder II (ADO II) in children. Methods: The clinical and follow-up data of 102 children who...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Diandong, Zhang, Jianjun, Fan, Youfei, Han, Bo, Zhao, Lijian, Yi, Yingchun, Lv, Jianli, Wang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185017/
https://www.ncbi.nlm.nih.gov/pubmed/34113582
http://dx.doi.org/10.3389/fped.2021.571407
_version_ 1783704696583618560
author Jiang, Diandong
Zhang, Jianjun
Fan, Youfei
Han, Bo
Zhao, Lijian
Yi, Yingchun
Lv, Jianli
Wang, Jing
author_facet Jiang, Diandong
Zhang, Jianjun
Fan, Youfei
Han, Bo
Zhao, Lijian
Yi, Yingchun
Lv, Jianli
Wang, Jing
author_sort Jiang, Diandong
collection PubMed
description Objective: The aim of this study was to assess the efficacy and safety of transcatheter retrograde closure of perimembranous ventricular septal defect (pmVSD) via the femoral artery with an Amplatzer Duct Occluder II (ADO II) in children. Methods: The clinical and follow-up data of 102 children who had successfully undergone transcatheter retrograde closure of pmVSD via the femoral artery with Amplatzer Duct Occluder II (ADO II) from February 2012 to June 2019 in our center were retrospectively reviewed. Results: In 102 of 103 patients, the defects were successfully closed (99.0%). The average age was 4.03 ± 1.84 years and the mean weight was 17.50 ± 5.58 kg. The mean diameter of the defects was 2.58 ± 0.63 mm. Hundred of the occluders had a waist length of 4 mm. The complete closure rate was 89.2% 24 h after the procedure and 98% at the last follow-up. The follow-up period ranged from 6 to 92 months, with a median of 36 months. One child developed new mild aortic regurgitation (AR), and 9 patients developed new mild tricuspid regurgitation (TR). During follow-up, TR disappeared in 5 patients and decreased in 4 patients, and AR relieved in one patient. One patient developed intermittent complete left bundle branch block 4 days after the procedure and recovered sinus rhythm 2 days later. No serious complications occurred. Conclusion: Transcatheter retrograde closure of pmVSD via the femoral artery with ADO II in children is safe, feasible, and effective in selected patients.
format Online
Article
Text
id pubmed-8185017
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81850172021-06-09 The Efficacy and Medium to Long-Term Follow-Up of Transcatheter Retrograde Closure of Perimembranous Ventricular Septal Defects via the Femoral Artery With Amplatzer Duct Occluder II in Children Jiang, Diandong Zhang, Jianjun Fan, Youfei Han, Bo Zhao, Lijian Yi, Yingchun Lv, Jianli Wang, Jing Front Pediatr Pediatrics Objective: The aim of this study was to assess the efficacy and safety of transcatheter retrograde closure of perimembranous ventricular septal defect (pmVSD) via the femoral artery with an Amplatzer Duct Occluder II (ADO II) in children. Methods: The clinical and follow-up data of 102 children who had successfully undergone transcatheter retrograde closure of pmVSD via the femoral artery with Amplatzer Duct Occluder II (ADO II) from February 2012 to June 2019 in our center were retrospectively reviewed. Results: In 102 of 103 patients, the defects were successfully closed (99.0%). The average age was 4.03 ± 1.84 years and the mean weight was 17.50 ± 5.58 kg. The mean diameter of the defects was 2.58 ± 0.63 mm. Hundred of the occluders had a waist length of 4 mm. The complete closure rate was 89.2% 24 h after the procedure and 98% at the last follow-up. The follow-up period ranged from 6 to 92 months, with a median of 36 months. One child developed new mild aortic regurgitation (AR), and 9 patients developed new mild tricuspid regurgitation (TR). During follow-up, TR disappeared in 5 patients and decreased in 4 patients, and AR relieved in one patient. One patient developed intermittent complete left bundle branch block 4 days after the procedure and recovered sinus rhythm 2 days later. No serious complications occurred. Conclusion: Transcatheter retrograde closure of pmVSD via the femoral artery with ADO II in children is safe, feasible, and effective in selected patients. Frontiers Media S.A. 2021-05-25 /pmc/articles/PMC8185017/ /pubmed/34113582 http://dx.doi.org/10.3389/fped.2021.571407 Text en Copyright © 2021 Jiang, Zhang, Fan, Han, Zhao, Yi, Lv and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Jiang, Diandong
Zhang, Jianjun
Fan, Youfei
Han, Bo
Zhao, Lijian
Yi, Yingchun
Lv, Jianli
Wang, Jing
The Efficacy and Medium to Long-Term Follow-Up of Transcatheter Retrograde Closure of Perimembranous Ventricular Septal Defects via the Femoral Artery With Amplatzer Duct Occluder II in Children
title The Efficacy and Medium to Long-Term Follow-Up of Transcatheter Retrograde Closure of Perimembranous Ventricular Septal Defects via the Femoral Artery With Amplatzer Duct Occluder II in Children
title_full The Efficacy and Medium to Long-Term Follow-Up of Transcatheter Retrograde Closure of Perimembranous Ventricular Septal Defects via the Femoral Artery With Amplatzer Duct Occluder II in Children
title_fullStr The Efficacy and Medium to Long-Term Follow-Up of Transcatheter Retrograde Closure of Perimembranous Ventricular Septal Defects via the Femoral Artery With Amplatzer Duct Occluder II in Children
title_full_unstemmed The Efficacy and Medium to Long-Term Follow-Up of Transcatheter Retrograde Closure of Perimembranous Ventricular Septal Defects via the Femoral Artery With Amplatzer Duct Occluder II in Children
title_short The Efficacy and Medium to Long-Term Follow-Up of Transcatheter Retrograde Closure of Perimembranous Ventricular Septal Defects via the Femoral Artery With Amplatzer Duct Occluder II in Children
title_sort efficacy and medium to long-term follow-up of transcatheter retrograde closure of perimembranous ventricular septal defects via the femoral artery with amplatzer duct occluder ii in children
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185017/
https://www.ncbi.nlm.nih.gov/pubmed/34113582
http://dx.doi.org/10.3389/fped.2021.571407
work_keys_str_mv AT jiangdiandong theefficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren
AT zhangjianjun theefficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren
AT fanyoufei theefficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren
AT hanbo theefficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren
AT zhaolijian theefficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren
AT yiyingchun theefficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren
AT lvjianli theefficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren
AT wangjing theefficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren
AT jiangdiandong efficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren
AT zhangjianjun efficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren
AT fanyoufei efficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren
AT hanbo efficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren
AT zhaolijian efficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren
AT yiyingchun efficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren
AT lvjianli efficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren
AT wangjing efficacyandmediumtolongtermfollowupoftranscatheterretrogradeclosureofperimembranousventricularseptaldefectsviathefemoralarterywithamplatzerductoccluderiiinchildren